1. Home
  2. JAGX vs ISPC Comparison

JAGX vs ISPC Comparison

Compare JAGX & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • ISPC
  • Stock Information
  • Founded
  • JAGX 2013
  • ISPC 2009
  • Country
  • JAGX United States
  • ISPC United States
  • Employees
  • JAGX N/A
  • ISPC N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • ISPC Precision Instruments
  • Sector
  • JAGX Health Care
  • ISPC Health Care
  • Exchange
  • JAGX Nasdaq
  • ISPC Nasdaq
  • Market Cap
  • JAGX 8.1M
  • ISPC 3.2M
  • IPO Year
  • JAGX N/A
  • ISPC 2021
  • Fundamental
  • Price
  • JAGX $8.51
  • ISPC $1.14
  • Analyst Decision
  • JAGX
  • ISPC
  • Analyst Count
  • JAGX 0
  • ISPC 0
  • Target Price
  • JAGX N/A
  • ISPC N/A
  • AVG Volume (30 Days)
  • JAGX 246.2K
  • ISPC 46.8K
  • Earning Date
  • JAGX 05-16-2025
  • ISPC 05-20-2025
  • Dividend Yield
  • JAGX N/A
  • ISPC N/A
  • EPS Growth
  • JAGX N/A
  • ISPC N/A
  • EPS
  • JAGX N/A
  • ISPC N/A
  • Revenue
  • JAGX $11,689,000.00
  • ISPC $9,291,115.00
  • Revenue This Year
  • JAGX $38.22
  • ISPC $35.93
  • Revenue Next Year
  • JAGX $39.96
  • ISPC N/A
  • P/E Ratio
  • JAGX N/A
  • ISPC N/A
  • Revenue Growth
  • JAGX 19.75
  • ISPC N/A
  • 52 Week Low
  • JAGX $4.02
  • ISPC $1.02
  • 52 Week High
  • JAGX $502.50
  • ISPC $11.80
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 46.54
  • ISPC 42.71
  • Support Level
  • JAGX $10.41
  • ISPC $1.09
  • Resistance Level
  • JAGX $13.20
  • ISPC $1.41
  • Average True Range (ATR)
  • JAGX 1.90
  • ISPC 0.08
  • MACD
  • JAGX 0.07
  • ISPC -0.00
  • Stochastic Oscillator
  • JAGX 29.02
  • ISPC 14.97

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Share on Social Networks: